McDonald J, Barnes T A, Okawa H, Williams J, Calo' G, Rowbotham D J, Lambert D G
University Department of Anaesthesia, Critical Care and Pain Management, Leicester Royal Infirmary, Leicester LE1 5WW.
Br J Pharmacol. 2003 Sep;140(1):61-70. doi: 10.1038/sj.bjp.0705401. Epub 2003 Aug 11.
(1) Partial agonism is primarily dependent upon receptor density and coupling efficiency. As these parameters are tissue/model dependent, intrinsic activity in different tissues can vary. We have utilised the ecdysone-inducible expression system containing the human nociceptin/orphanin FQ (N/OFQ) peptide receptor (hNOP) expressed in Chinese hamster ovary cells (CHOINDhNOP) to examine the activity of a range of partial agonists in receptor binding, GTPgamma35S binding and inhibition of adenylyl cyclase studies. (2) Incubation of CHOINDhNOP cells with ponasterone A (PON) induced hNOP expression ([leucyl-3H]N/OFQ binding) of 24, 68, 191 and 1101 fmol mg-1 protein at 1, 2, 5 and 10 microm PON, respectively. At 191 fmol mg-1, protein hNOP pharmacology was identical to that reported for other traditional expression systems. (3) pEC50 values for GTPgamma35S binding ranged from 7.23 to 7.72 (2-10 microm PON) for the partial agonist [Phe1psi(CH2-NH)Gly2]N/OFQ(1-13)-NH2 ([F/G]N/OFQ(1-13)-NH2) and 8.12-8.60 (1-10 microm PON) for N/OFQ(1-13)-NH2 and Emax values (stimulation factor relative to basal) ranged from 1.51 to 3.21 (2-10 microm PON) for [F/G]N/OFQ(1-13)-NH2 and 1.28-6.95 (1-10 microm) for N/OFQ(1-13)-NH2. Intrinsic activity of [F/G]N/OFQ(1-13)-NH2 relative to N/OFQ(1-13)-NH2 was 0.3-0.5. [F/G]N/OFQ(1-13)-NH2 did not stimulate GTPgamma35S binding at 1 microm PON, but competitively antagonised the effects of N/OFQ(1-13)-NH2 with a pKB=7.62. (4) pEC50 values for cAMP inhibition ranged from 8.26 to 8.32 (2-10 microm PON) for [F/G]N/OFQ(1-13)-NH2 and 9.42-10.35 for N/OFQ(1-13)-NH2 and Emax values (% inhibition) ranged from 19.6 to 83.2 for [F/G]N/OFQ(1-13)-NH2 and 40.9-86.0 for N/OFQ(1-13)-NH2. The intrinsic activity of [F/G]N/OFQ(1-13)-NH2 relative to N/OFQ(1-13)-NH2 was 0.48-0.97. (5) In the same cellular environment with receptor density as the only variable, we show that the profile of [F/G]N/OFQ(1-13)-NH2 can be manipulated to encompass full and partial agonism along with antagonism.
(1) 部分激动作用主要取决于受体密度和偶联效率。由于这些参数依赖于组织/模型,不同组织中的内在活性可能会有所不同。我们利用了在中华仓鼠卵巢细胞(CHOINDhNOP)中表达的含人孤啡肽/孤啡肽FQ(N/OFQ)肽受体(hNOP)的蜕皮激素诱导表达系统,来研究一系列部分激动剂在受体结合、GTPγ35S结合和腺苷酸环化酶抑制研究中的活性。(2) 用ponasterone A(PON)孵育CHOINDhNOP细胞,在1、2、5和10微摩尔PON时,诱导的hNOP表达([亮氨酰 - 3H]N/OFQ结合)分别为24、68、191和1101飞摩尔/毫克蛋白。在191飞摩尔/毫克蛋白时,hNOP药理学与其他传统表达系统报道的相同。(3) 部分激动剂[Phe1ψ(CH2 - NH)Gly2]N/OFQ(1 - 13)-NH2([F/G]N/OFQ(1 - 13)-NH2)在GTPγ35S结合中的pEC50值在2 - 10微摩尔PON范围内为7.23至7.72,N/OFQ(1 - 13)-NH2的为8.12 - 8.60,Emax值(相对于基础的刺激因子)在2 - 10微摩尔PON范围内,[F/G]N/OFQ(1 - 13)-NH2为1.51至3.2l,N/OFQ(1 - 13)-NH2为1.28 - 6.95。[F/G]N/OFQ(1 - 13)-NH2相对于N/OFQ(1 - 13)-NH2的内在活性为0.3 - 0.5。[F/G]N/OFQ(1 - 13)-NH2在1微摩尔PON时不刺激GTPγ35S结合,但以pKB = 7.62竞争性拮抗N/OFQ(。(4) [F/G]N/OFQ(1 - 13)-NH2在cAMP抑制中的pEC50值在2 - 10微摩尔PON范围内为8.26至8.32,N/OFQ(1 - 13)-NH2的为9.42 - 10.35,Emax值(抑制百分比),[F/G]N/OFQ(1 - 13)-NH2为19.6至83.2,N/OFQ(1 - 13)-NH2为40.9 - 86.0。[F/G]N/OFQ(1 - 13)-NH2相对于N/OFQ(1 - 13)-NH2的内在活性为0.48 - 0.97。(5) 在受体密度为唯一变量的相同细胞环境中,我们表明[F/G]N/OFQ(1 - 13)-NH2的作用模式可以被调控,以涵盖完全激动、部分激动以及拮抗作用。